Research on the Oxford Vaccine found that the vaccine is effective on all types of variants. However, this research has not been published yet.
Covishield Vaccine (File Photo)
In many countries of the world, including India, people are being vaccinated with the Corona Vaccine of Oxford and AstraZeneca. After the new variants of the virus appeared, questions were arising in the minds of the people whether the corona vaccine would work against the new variant or not? In such a situation, the good news is that the AstraZeneca company has prepared the Booster Dose of the vaccine. This dose has been found to be effective in producing strong antibodies (anti-body) against the spike proteins of the corona.
In the report of the British newspaper Financial Times, it was informed by quoting a research. Let us know that the vaccine manufacturers have warned that to avoid the Corona variant, booster dose may have to be applied every year. Research on the Oxford vaccine has found that the vaccine is effective on all types of variants. New variants of adenovirus have been used in the manufacture of boosters. However, this research has not been published yet.
Competition for booster dose
Some scientists say that if a booster dose is administered every year to avoid the corona variant, it may affect the effect of the vaccine. Although it is not yet known how long Oxford University’s research will be published, but as soon as this information is revealed, there is a competition for boosters in the world. The European Union has already made deals with the Pfizer company for billions of doses.
Covishield from Oxford and AstraZeneca is the corona vaccine, with very good results. Its efficacies are also high and it is capable of preventing the risk of infection and death of the corona. This vaccine is being used in India and many countries of the world. By April 27, 2021, 13.4 crore doses have been given to the people. The Ministry of Health is closely monitoring the vaccines of COVID-19 and all the safety norms are being monitored. Any adverse effect is being investigated anywhere.
‘Kovishield’ engulfed in controversies
This vaccine had come into controversy after the news of blood clots forming after applying Kovishield. Many countries of Europe have also put a temporary ban on this vaccine. In view of the danger, a British scientist has advised those below 40 years to get vaccinated. However, after taking the vaccine in India, there are very few complaints of bleeding (bleeding) and clotting (blood clotting). As the work of vaccination will increase, there may be an increase in it.
Also Read: ‘Crazy and Corrupt Man’ is Trump! Obama says hateful words for former president in new book, Kamala Harris also targeted
Also read: Despite ‘defeating’ Corona, why now the case in Singapore-Taiwan increased? After all, where did the mistake happen and how can India also take a ‘lesson’
.